Saiid Zarrabian

Saiid Zarrabian has a diverse and extensive background in the biotechnology and pharmaceutical sectors, currently serving as the Head of Strategic Partnerships and a member of the Board of Directors for Kintara Therapeutics, Inc. since May 2018. At Kintara, a late-stage oncology company, Zarrabian oversees programs focused on treatments for underrepresented patient populations. Previous leadership roles include President and CEO of DelMar Pharmaceuticals, and various executive positions at companies such as Immune Therapeutics, La Jolla Pharmaceuticals, Intrexon, and Cyntellect. With a career also marked by consultancy through Zarrabian Consulting, Saiid Zarrabian has been instrumental in advancing oncology and biopharmaceutical initiatives.